Optimal Heating Temperature in Major Burns Patients

May 15, 2020 updated by: Alonso Fernández, Juan Manuel, University Rovira i Virgili

Clinical Optimization of Ambient Temperature and Heating Methods in Caring in Major Burns Patients

pre and post intervention quasi-experimental epidemiological study without a control group will be carried out in large burned patients that will evaluate the influence on metabolic expenditure of the inclusion of active external rewarming in the control of body temperature.

Study Overview

Detailed Description

the heavily burned patient requires specific care to prevent hypothermia and maintain body temperature. You are at high risk of developing hypothermia in the acute phase due to heat losses from convection, radiation, evaporation, and conduction. After the acute phase, the patient due to physiological mechanisms and the hypermetabolic response mainly demands a temperature close to 38.5ºC, ruling out the infectious focus. According to the authors, environmental temperatures between 28-33ºC are recommended for the care of these patients to decrease energy expenditure. The research carried out has studied the influence of passive external heating (environmental regulation), without including the influence of active external heating (heat blankets, heating plate ...) or the study of the thermal comfort of large burned patients and of professionals who provide them they attend.

A pre and post intervention quasi-experimental epidemiological study without a control group will be carried out in large burned patients that will evaluate the influence on metabolic expenditure of the inclusion of active external rewarming in the control of body temperature. Metabolic expenditure will be measured by indirect calorimetry in the usual treatment with passive external rewarming and post-intervention in the combination of passive and active external heating. The combination of passive and active external reheating will previously study the operating temperature in various cases for optimal application, as well as the definition of thermal comfort in the large burn unit. The specific training of the personnel involved in the care of these patients will be required for the application of the evidence-based recommendations and the evaluation of their implementation.

Study Type

Interventional

Enrollment (Anticipated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Juan Manuel Alonso Fernández, MSN
  • Phone Number: 0034679660502
  • Email: jmalonsof@gmail.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients over 18 years of age.
  • Patients with thermal burns.
  • Patient with high burn criteria according to ABA:
  • 2nd degree burn
  • Patient 18 - 59 years: SCQ> 20%
  • Patient> 60 years or pathology: SCQ> 10%
  • 3rd degree burn
  • SCQ> 10%
  • Patients on mechanical ventilation

Exclusion Criteria:

  • Sepsis criteria according to ABA.
  • Enzyme debridement application (data within 24 hours).
  • 6 hours after a surgical intervention.
  • After 2 hours after healing burns
  • Patients in hemorrhagic shock

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Passive external overheating

Passive external overheating in the environmental temperature control adjusted to thermal comfort.

Measure during 6 hours with indirect calorimetry

Active Comparator: Active external overheating with heating plate
Combination of passive and active external heating with heating plate Measure during 6 hours with indirect calorimetry
It is a heating device that is adjustable in height up to 50 cm from the patient and generates radiant heat at low temperature (up to 39 ◦C) distributed evenly. It is equipped with an adjustable 0-9 potentiometer and has a skin temperature probe as a control and safety mechanism Measure during 6 hours with indirect calorimetry in first week
Other Names:
  • Aspira Medical AB Aragonia ® MTC 400. Certificate CE 0413
Active Comparator: Active external overheating with air blanket
Combination of passive and active external heating with convective air blanket Measure during 6 hours with indirect calorimetry
Composed of a unit that produces hot air and forced air adjustable from 38ºC to 43ºC. Sends hot forced air distributed by tubular blanket that convectively heats the patient by diffusing hot air directed at the patient through the textile pore of the air blanket Measure during 6 hours with indirect calorimetry in first week
Other Names:
  • Equator Level 1® de Smiths Medical REF EQ-5000. Certificate CE 0473

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Metabolic expenditure
Time Frame: Measure during 6 hours with indirect calorimetry in first recovery week with three heating methods
Compare the metabolic expenditure of burned patients according to the heating method between the combination of active and passive external adjusted to thermal comfort versus external passive overheating.
Measure during 6 hours with indirect calorimetry in first recovery week with three heating methods

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Optimal environmental temperature
Time Frame: Measure during 6 hours with three heating methods in first recovery week
Define the optimal environmental temperature according to the characteristics of the patient with a large burn during the acute phase, assigning the available resources.
Measure during 6 hours with three heating methods in first recovery week
Thermal comfort
Time Frame: Measure during 6 hours with three heating methods first recovery week
Analyze thermal comfort according to heating methods in large burned patients.
Measure during 6 hours with three heating methods first recovery week

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nursing care planning
Time Frame: Measure Scales during three heating methods in six hours, first recovery week
Evaluate the nursing care plan in the thermoregulation of the burned patient according to the standardized nurse taxonomy.
Measure Scales during three heating methods in six hours, first recovery week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Juan Manuel Alonso Fernández, MSN, Sanidad Castilla y León

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2020

Primary Completion (Anticipated)

March 1, 2022

Study Completion (Anticipated)

October 1, 2022

Study Registration Dates

First Submitted

May 6, 2020

First Submitted That Met QC Criteria

May 15, 2020

First Posted (Actual)

May 21, 2020

Study Record Updates

Last Update Posted (Actual)

May 21, 2020

Last Update Submitted That Met QC Criteria

May 15, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HEATINGBURNS01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burns

3
Subscribe